CA
PPH icon

Cetera Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cetera Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$606K Buy
+6,682
New +$585K ﹤0.01% 1482
2019
Q2 		– Sell
-100
Closed -$6K – 1188
2019
Q1 		$6K Buy
+100
New +$5.91K ﹤0.01% 1173

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cetera Advisors's PPH Position: Q1 2024 in Review

Cetera Advisors opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2024: 6,682 shares worth $606K. The stake represents ﹤0.01% of the portfolio and ranks #1482 among its holdings. This is a return to the name: Cetera Advisors previously reported a position in PPH as recently as Q1 2019.

Cetera Advisors first reported a position in PPH in Q1 2019 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

  • Cetera Advisors held 6,682 shares of VanEck Pharmaceutical ETF worth $606K as of Q1 2024.
  • VanEck Pharmaceutical ETF was a new Cetera Advisors position in Q1 2024.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1482 holding.
  • Cetera Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2019 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.